Key facts
- It has raised $750K; the latest was Later Stage VC in Mar 2026.
- Notable investors include Südlich Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Rubisco
- ·The full record, as it builds
Funding rounds
No funding rounds for Rubisco are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rubisco
Developer of plant cell culture-derived natural active ingredients designed for sustainable industrial-scale cosmetic and skincare applications. The company's platform leverages proprietary biotechnology to cultivate native and endangered plant species under controlled, aseptic conditions, free from herbicides and pesticides, enabling businesses to access consistent, standardized, and environmentally responsible bioactive compounds at scalable costs.
- Sector
- Healthcare
- HQ
- Santiago, Chile
- Founded
- 2015
- Employees
- 10
- Website
- rubiscolab.com/
- Ownership
- Privately Held (backing)
Rubisco doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rubisco shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rubisco in its N-PORT filings yet. We sweep new filings monthly.